NM_000103.4:c.-39+16786G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000103.4(CYP19A1):c.-39+16786G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 152,148 control chromosomes in the GnomAD database, including 26,944 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.56 ( 26939 hom., cov: 32)
Exomes 𝑓: 0.38 ( 5 hom. )
Consequence
CYP19A1
NM_000103.4 intron
NM_000103.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.429
Publications
10 publications found
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
MIR4713HG (HGNC:53124): (MIR4713 host gene)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.836 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP19A1 | NM_000103.4 | c.-39+16786G>C | intron_variant | Intron 1 of 9 | ENST00000396402.6 | NP_000094.2 | ||
| LOC112268146 | XR_002957708.2 | n.1213C>G | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||
| CYP19A1 | NM_001347248.1 | c.-39+2107G>C | intron_variant | Intron 1 of 9 | NP_001334177.1 | |||
| CYP19A1 | NM_031226.3 | c.-39+2107G>C | intron_variant | Intron 2 of 10 | NP_112503.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.564 AC: 85753AN: 151938Hom.: 26866 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
85753
AN:
151938
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.380 AC: 35AN: 92Hom.: 5 Cov.: 0 AF XY: 0.394 AC XY: 26AN XY: 66 show subpopulations
GnomAD4 exome
AF:
AC:
35
AN:
92
Hom.:
Cov.:
0
AF XY:
AC XY:
26
AN XY:
66
show subpopulations
African (AFR)
AF:
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
29
AN:
82
Other (OTH)
AF:
AC:
2
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.565 AC: 85886AN: 152056Hom.: 26939 Cov.: 32 AF XY: 0.559 AC XY: 41509AN XY: 74320 show subpopulations
GnomAD4 genome
AF:
AC:
85886
AN:
152056
Hom.:
Cov.:
32
AF XY:
AC XY:
41509
AN XY:
74320
show subpopulations
African (AFR)
AF:
AC:
34979
AN:
41498
American (AMR)
AF:
AC:
9005
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1504
AN:
3464
East Asian (EAS)
AF:
AC:
3008
AN:
5146
South Asian (SAS)
AF:
AC:
2441
AN:
4810
European-Finnish (FIN)
AF:
AC:
3232
AN:
10566
Middle Eastern (MID)
AF:
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30091
AN:
67972
Other (OTH)
AF:
AC:
1176
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1669
3338
5008
6677
8346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2036
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.